(2019)
ApoE attenuates unresolvable inflammation by complex formation with activated C1q.
Nat Med 25(3),
496-506.
Publikationen
(2019)
The Case: A 78-year-old woman with acute kidney injury and hemolytic anemia.
Kidney Int 95(2),
473-474.
(2019)
C3-glomerulopathy autoantibodies mediate distinct effects on complement C3- and C5-convertases.
Front Immunol 10,
1030.
(2019)
Complement inhibitors in clinical trials for glomerular diseases.
Front Immunol 10,
2166.
(Review)
(2018)
Aspf2 from Aspergillus fumigatus recruits human immune regulators for immune evasion and cell damage.
Front Immunol 9,
1635.
(2018)
Modeling hemolytic-uremic syndrome: In-depth characterization of distinct murine models reflecting different features of human disease.
Front Immunol 9,
1459.
(2018)
Formation of nudicaulins In Vivo and In Vitro and the biomimetic synthesis and bioactivity of O-methylated nudicaulin derivatives.
Molecules 23(12),
3357.
(2018)
Precursor-directed diversification of cyclic tetrapeptidic pseudoxylallemycins.
ChemBioChem 19(21),
2307-2311.
(2018)
Playing 'hide-and-seek' with factor H: game-theoretical analysis of a single nucleotide polymorphism.
J R Soc Interface 15(142),
20170963.
(2018)
Kallikrein cleaves C3 and activates complement.
J Innate Immun 10(2),
94-105.